Like most other Black men, I have had extremely inconsistent engagement with healthcare. If I’m not sick, why go? Until recently, the only time I really cared to access any type of care was when I was getting tested for HIV and other STIs.
In 2012, while conducting research at Fenway Health, I learned that multiple studies were trying to assess how effective taking one pill, once a day, would be at preventing HIV infection. My colleagues and I would joke about taking this pill once it became available, if it was successful. And then “BOOM,” there it was—a one-a-day pill that could prevent HIV by close to 100 percent. Continue reading →
January 15, 2015, Washington, DC – The ADAP Crisis Task Force (Task Force) has reached a new pricing agreement between AbbVie and AIDS Drug Assistance Programs (ADAPs) for Viekira Pak (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets) for the treatment of hepatitis C (HCV). AbbVie is the first company to offer a discount on the ADAP price of an HCV medication in the era of new curative HCV treatments. The agreed-upon ADAP price for Viekira Pak, negotiated between the Task Force and AbbVie, reflects voluntary discounts and rebates that are significantly lower than the wholesale acquisition cost (WAC). While many ADAPs may not be able to add Viekira Pak to their formularies due to fiscal constraints, this agreement recognizes the importance of access to hepatitis C medications for people living with HIV and demonstrates good faith that access at a discounted price may lead to formulary inclusion. ADAPs make individual decisions about adding new medications to their formularies. Continue reading →
While some may choose to remember former Governor Mario M. Cuomo for the two chartered airplanes on the tarmac in December 1991 and a legacy lacking a signature initiative, I choose to remember the late Governor for setting the stage for Governor Andrew M. Cuomo’s “Plan to End the AIDS Epidemic in New York State.” What has yet to be said in the news of Governor Cuomo’s passing is that in addition to a recession and divided legislature, Governor Mario M. Cuomo led New York State at the height of the AIDS epidemic when there was very little to offer those who were sick and dying rapidly. In 1983 when Governor Cuomo took office very little was known about AIDS – the case definition had just come out in September of 1982. By the end of Governor Cuomo’s first year in office, New York State had 1,373 cumulative cases of AIDS, 44.8% of the national total reported to the Centers for Disease Control and Prevention (CDC) by that time. Continue reading →
By Michelle Allen, Senior Associate, Communications, NASTAD
As we prepare to close out the year, we at NASTAD are looking back at some of the stories and content that generated the most interest on website and blog in 2014. We encourage you to revisit these stories and share the information as you prepare your jurisdiction or organization for the New Year. Continue reading →